Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Merck releases results from successful trial of Winrevair
Merck's phase 3 Hyperion study showed that Winrevair reduced the risk of clinical worsening events by 76% in recently diagnosed adults with PAH.
Kevin Dunleavy
Sep 30, 2025 8:00am
England is not attractive place for investment, Lilly CEO says
Sep 24, 2025 10:52am
Merck, St. Louis Cardinals pitch heart disease awareness push
Sep 17, 2025 4:58pm
Merck touts Capvaxive's potential to provide protection for kids
Sep 11, 2025 11:12am
Fierce Biotech
Merck scraps £1B project, along with all R&D operations in UK
Sep 10, 2025 3:40pm
Big Pharma bounces back in Q2
Aug 22, 2025 9:09am
